Notes from the East
Woods
musings on opportunities in the life science
marketplace
November 2009
|
|
|
|
Greetings!
|
This month, we see how being exposed to the weather is the best way to find new opportunties. Please have a read and feel free to let me know what you think. Thanks.
Regards,
Paul Danis
Founder and Principal
ps. We have updated our website and included past Notes so you can peruse them here.
|
|
|
|
|
|
Watatic and New Business
|
 Standing on the top of Mt. Watatic
last weekend with a view in all directions, it became clear to me why Google
Earth is so limited. With wind in my
face I could not only see distant lakes and mountains, but I had a sense of
what they were like. It is this "sense"
of things that that will never happen on your desktop screen as you visit
fascinating places. This gap in
understanding is the same thing that occurs when one creates a strategic plan
or operating process based on their ideas and intuition garnered from
discussions with the folks down the hall.
This internal approach has the advantage of being relatively quick, but
is far riskier than a fully vetted approach driven by the marketplace.
Since the goal usually is to find new opportunities and grow
the business, the last thing you need is the all too common s.p.o.t.s syndrome
or strategic plan on top shelf [gathering dust].
You need a realistic assessment of the new business you can expect to win, a well though-out approach to get it, and the willingness to see it
through
By basing your plans, hopes, and operations on the real situation
instead of the hypothetical, success is far more likely. Many good things happen when you are immersed in the marketplace and all of
its dynamics.
-
With a realistic foundation, successfully executing the plan
is far more likely than if it is based on a veneer of hope.
-
People in your organization will be more inspired since it will reflect what they are seeing in the market.
-
You can build and cement relationships with customers, partners,
and others who can provide important resources.
-
You will have your finger on emerging opportunities before
your competition.
-
You'll make products that solve the important problems,
and you will know when to ramp up demand and drive the needed
sales.
-
You will be confident that
folks in your company are working on the most valuable products,
markets, and activities.
So to get the best out of your organization and find new
opportunities, don't build your plans while you are exploring the two dimensional
view from your screen. Go out into the
elements, feel the wind on your face, and get a real understanding of where you
need to go.
|
Life Science Market Update
|
|
Index
|
October Value
|
Change YTD
|
Yearly High
|
Yearly Low
|
|
EC BioTools
|
615
|
38%
|
639
|
411
|
|
EC BigPharma
|
793
|
7%
|
795
|
617
|
|
EC Biotech
|
504
|
-1%
|
556
|
446
|
Six months of rising tides came to an end as all indices are down for the month, with BioTools off 4% and Biotech falling 9%. For BioTools and BigPharma, declines led advances 3 to 1, while Biotech was at 6 to 1. Big losers were Affymetrix and Illumina losing 40% and 24% of their value over last month's close due to poor Q3 revenue and lowered forecasts. Sepracor is also no longer part of the Biotech index after its acquisition by Dainippon Sumitomo Pharma Co. It is replaced by Dendreon Corp.
EC BioIndex October 2009
---------------------
Many of the life science
indices currently available are a mixture of various types of companies. In
order to better assess the situation in the different segments, Eastwoods
Consulting has created these price-weighted indices for the sectors of large
pharmaceutical companies, biotech companies, and life science research tools
companies.
-
EC BioTools Index - A, ACCL, AFFX, BEC, BIO, BRKR,
CALP, DNEX, HBIO, HLCS, ILMN, LIFE, LMNX, PKI, QGEN, SIAL,
TMO, VARI, WAT
-
EC BigPharma Index - JNJ, PFE, GSK, NVS, SNY, MRK, ABT,
LLY, AZN, WYE, BMY, NVO, BAX, TEVA, SGP, ROG.VX
-
EB Biotech Index - AMGN, GENZ, BIIB, CEPH, GILD,
BMRN, AMLN, IDXX, SEPR, OSIP, PDLI, CPHD, ALKS, REGN, VRTX, THRX, HGSI, SGMO, NKTR
-
Prices are
taken at the close of each month. YTD is the year to date change taken from the end of December, 2008.
|
|
| About Eastwoods Consulting
|
Translating Innovations into Profits for the Life Science IndustrytmEastwoods Consulting helps life science companies grow their businesses. Please visit our web site or contact us to learn more about how we help companies succeed in competitive markets.
|
Copyright © 2009, Eastwoods Consulting. This
publication may be freely redistributed in full or in part as long as full
attribution including our contact information and web address, are included. Eastwoods is a registered servicemark of Eastwoods Consultng.
|
|
|
|
|
